Status 2 upgrade indication impacts posttransplant mortality in patients bridged with intraaortic balloon pump in the new heart allocation system

Am J Transplant. 2024 May;24(5):818-826. doi: 10.1016/j.ajt.2023.12.009. Epub 2023 Dec 14.

Abstract

To evaluate outcomes of patients undergoing heart transplants (HTs) using an intra-aortic balloon pump (IABP) under exception status. Adult patients supported by an IABP who underwent HT between November 18, 2018, and December 31, 2020, as documented in the United Network for Organ Sharing, were included. Patients were stratified according to requests for exception status. Kaplan-Meier methodology was used to look for differences in survival between groups. A total of 1284 patients were included; 492 (38.3%) were transplanted with an IABP under exception status. Exception status patients had higher body mass index, were more likely to be Black, and had longer waitlist times. Exception status patients received organs from younger donors, had a shorter ischemic time, and had a higher frequency of sex mismatch. The 1-year posttransplant survival was 93% for the nonexception and 88% for the exception IABP patients (hazard ratio: 1.85 [95% confidence interval: 1.12-2.86, P = .006]). The most common reason for requesting an exception status was inability to meet blood pressure criteria for extension (37% of patients). The most common reason for an extension request for an exception status was right ventricular dysfunction (24%). IABP patients transplanted under exception status have an increased 1-year mortality rate posttransplant compared with those without exception status.

Keywords: heart allocation system; heart transplant; intraaortic balloon pump.

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Graft Survival*
  • Heart Failure / mortality
  • Heart Failure / surgery
  • Heart Transplantation* / mortality
  • Heart-Assist Devices
  • Humans
  • Intra-Aortic Balloon Pumping* / mortality
  • Male
  • Middle Aged
  • Postoperative Complications / mortality
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Tissue Donors / supply & distribution
  • Tissue and Organ Procurement*
  • Waiting Lists* / mortality